Literature DB >> 2556276

Fluconazole therapy in an underweight infant.

C Viscoli1, E Castagnola, M Corsini, R Gastaldi, M Soliani, A Terragna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2556276     DOI： 10.1007/BF01963785

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  3 in total

Review 1.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

Authors:  P F Troke; R J Andrews; K W Brammer; M S Marriott; K Richardson
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 3.  New antifungal agents.

Authors:  J R Graybill
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267
  3 in total
  5 in total

1.  Fluconazole in neonatal disseminated candidiasis.

Authors:  D B Wiest; S L Fowler; S S Garner; D R Simons
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

Review 2.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 3.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

4.  Fluconazole in the treatment of candidiasis in immunocompromised children.

Authors:  C Viscoli; E Castagnola; F Fioredda; B Ciravegna; G Barigione; A Terragna
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 5.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.